Effect of Memantine on Moderate TBI

Clinical Updates in Brain Injury Science Today

Dr. Don Marion and Dr. Anne Bunner discuss whether a drug known for treating Alzheimer’s, which may have some neuroprotective effects, could improve short-term neurological function in patients with moderate TBI. Publication: Mokhtari, M., Nayeb-Aghaei, H., Kouchek, M., Miri, M.M., Goharani, R., Amoozandeh, A., Akhavan Salamat, S., Sistanizad, M. (2017). Effect of Memantine on Serum Levels of Neuron-Specific Enolase and on the Glasgow Coma Scale in Patients With Moderate Traumatic Brain Injury. Journal of Clinical Pharmacology. Epub ahead of print. doi: 10.1002/jcph.980 PubMed link: https://www.ncbi.nlm.nih.gov/pubmed/28724200 CUBIST is a podcast for health care providers produced by the Defense and Veterans Brain Injury Center. We discuss the latest research on traumatic brain injury (TBI) most relevant to patient care. For more about TBI, including clinical tools, go to dvbic.dcoe.mil or email us at [e-mail]. The views, opinions and/or findings contained in this podcast are those of the host and subject matter experts. They should not be construed as an official Department of Defense position, policy or decision unless so designated by other official documentation. All music in this podcast was used according to Creative Commons licensing. Our theme song is "Dog Wind" by Skill_Borrower, and our credit music is "Esaelp Em Xim" by Pitx, both from CCmixter.org.